The DOH announcement, dated December 27, said limited supply of oral antivirals will “require providers to prioritize treatment for patients at highest risk for severe COVID-19 until more product becomes available.”
Under a list of eligibility requirements for oral antiviral treatment, it said one requirement should be “have a medical condition or other factors that increase their risk for severe illness” and that one risk factor is being a “non-white race or Hispanic/Latino ethnicity should be considered a risk factor, as longstanding systemic health and social inequities have contributed to an increased risk of severe illness and death from COVID-19.”
The announcement also linked to a separate undated DOH document on prioritization that contained the same guidance.
Columnist Karol Markowicz drew attention to the guidelines in a tweet, where she said, “NY State Department of Health warns they don’t have enough Paxlovid or Monoclonal Antibody Treatment and white people need not apply.”
Trump’s Secret Legacy Is Set To Create Small Fortunes!
Developing Story - Trump administration oversaw a RADICAL change to the tech world… one that could unleash a huge wave prosperity… and wealth creation in the near future. Find Out More
Journalist and author Abigail Shrier called for a constitutional challenge to the guidance. “If the state can discriminate racially for medical treatment, then the 14th Amendment truly has no meaning. There needs to be a constitutional challenge to this IMMEDIATELY,” she tweeted.
Former Trump administration adviser Stephen Miller placed blame on the signal sent by the Biden Administration. He tweeted:
Political commentator Dave Rubin tweeted: “Systemic racism, brought to you by progressive Democrats…”
Follow Breitbart News’s Kristina Wong on Twitter or on Facebook.
Jeff Bezos’ Big Bet
World’s 2nd-Richest Man’s Latest Bombshell
The fuse has already been lit... and on March 9th I believe he’ll reveal a few more details. If you missed out on taking advantage of the Amazon success story... don’t miss out again. Find Out More